Company Long-Term Loans and Borrowings: Barinthus Bio (BRNS)
Barinthus Biotherapeutics (BRNS) specializes in T-cell immunotherapy, utilizing a proprietary platform to combat oncology and infectious threats, including hepatitis B. The market dynamics reflected in the price action demonstrate long-term debt at 0.01. The firm's revenues will grow through the implementation of VTP drugs, and the current strategy involves a revision of vaccination programs supported by strategic partners among the largest pharma behemoths.
Barinthus Bio (BRNS) - metric breakdowns and financial figures
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Barinthus Biotherapeutics|BRNS - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Barinthus Biotherapeutics Corp|BRNS - Company Debts|Debt to Book Value Barinthus Biotherapeutics|BRNS - Company Long-Term Debt|Company Current Liabilities Barinthus Biotherapeutics|Quick Ratio barinthusbio.com
- earnings and multiples data:
Analysis of all company metrics:BRNS - barinthusbio.com
This indicator aggregates the total volume of liabilities with maturities exceeding one year, allowing for an assessment of the issuer's long-term credit burden and the sustainability of its financial policy. By analyzing the long-term loans and borrowings chart of the corporation for portfolio stress testing, an investor can see the balance between debt capital and effective outsourcing of clinical trials, which minimizes the operational risks of Barinthus Biotherapeutics (BRNS).
Competitors of Barinthus Biotherapeutics (BRNS)
Company Long-Term Debts argenx.com ARGX|BNTX - Company Long-Term Debt|Company Long-Term Loans and Borrowings ABVX (abivax.com)|ADMA Bio (ADMA) - Company Long-Term Debt|Company Long-Term Liabilities Protagonist Corp|IMVT (Immunovant, Inc.) - Company Long-Term Debts|Company Long-Term Debts kiniksa.com|Company Long-Term Liabilities GRFS (Grifols)|ADPT (Adaptive Biotech) - Company Long-Term Loans and Borrowings|Company Long-Term Debts CLDX (Celldex)|Long-Term Debt Volume Aurinia Corp (AUPH)|BCRX - Company Long-Term Debt|veratx.com (VERA) - Company Long-Term Liabilities|Dianthus Therapeutics, Inc. (DNTH) - Company Long-Term Debt|Company Long-Term Liabilities Pharvaris NV|Company Long-Term Liabilities ABCL|Company Long-Term Debts Tourmaline|Company Long-Term Debt Precigen, Inc. (PGEN)|pharming.com - Company Long-Term Indebtedness|Company Long-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Long-Term Debt|Zenas Biopharma, Inc. - Company Long-Term Debts|IMNM: Company Long-Term Debt|GOSS: Company Long-Term Debts|kalvista.com (KALV) - Company Long-Term Debts|Company Long-Term Debt Septerna|PVLA: Company Long-Term Loans and Borrowings|Company Long-Term Debts SVRA|Long-Term Debt Volume Rigel Corp|Company Long-Term Debt AnaptysBio, Inc. ANAB|ATXS: Company Long-Term Indebtedness|ENGN: Company Long-Term Liabilities|rapt.com - Amount of Long-Term Liabilities|JBIO: Company Long-Term Debts|Aclaris Therapeutics, Inc - Company Long-Term Loans and Borrowings|Company Long-Term Liabilities KYTX|Company Long-Term Debts tizianalifesciences.com|Company Long-Term Debt Cabaletta Bio (CABA)|Long-Term Debt Volume Ventyx Biosciences Inc.|Theratechnologies Inc - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings AVTX|Eledon Pharmaceuticals - Company Long-Term Debts|AGEN: Company Long-Term Debt|CLYM: Company Long-Term Debts|ZURA - Long-Term Debt Volume|Company Long-Term Debt aTyr|Long-Term Debt Adagene Corp ADAG|Company Long-Term Liabilities IMA (ImageneBio Inc)|Amount of Long-Term Liabilities STTK|Company Long-Term Debts EQ (Equillium)|Company Long-Term Loans and Borrowings CNTB|Immunic Inc - Company Long-Term Debts|Long-Term Debt Atara Biotherapeutics|inflarx.de (IFRX) - Company Long-Term Debt|x4pharma.com - Company Long-Term Loans and Borrowings|ACET (Adicet Bio Inc.) - Company Long-Term Debts|Company Long-Term Debts Celularity Corp|Company Long-Term Debt INmune Bio Corp (INMB)|KZR: Long-Term Liabilities|Company Long-Term Debts SABS (SAB Biotherapeutics)|akaritx.com (AKTX) - Long-Term Debt|ENLV: Company Long-Term Liabilities|QTTB - Company Long-Term Debts|GOVX (GeoVax Labs Inc) - Company Long-Term Liabilities|EDSA: Amount of Long-Term Liabilities|IBIO (iBio, Inc.) - Company Long-Term Debts|Carisma Tx (CARM) - Long-Term Debt Volume|Company Long-Term Debts XTLB|Company Long-Term Liabilities boltbio.com BOLT|Company Long-Term Debt HCW Biologics HCWB|Long-Term Debt Volume Aptevo Therapeutics, Inc. (APVO)|AIM ImmunoTech - Company Long-Term Debts|ADTX: Company Long-Term Debt|GRI Bio (GRI) - Company Long-Term Debt|XORTX Therapeutics Inc - Company Long-Term Loans and Borrowings|Company Long-Term Debt ReShape Lifesciences|Company Long-Term Indebtedness REVB (Revelation Biosciences Corp)|Company Long-Term Debt Indaptus Therapeutics (INDP)|Long-Term Debt Volume scinai.com|Company Long-Term Debt CalciMedica CALI|AFMD (Affimed NV) - Long-Term Liabilities|Allakos Therapeutics - Company Long-Term Debts|Company Long-Term Loans and Borrowings HOOK (HOOKIPA Pharma Inc.)|IGMS: Company Long-Term Debts|iteostherapeutics.com (ITOS) - Company Long-Term Debts|Company Long-Term Debt Ocean Biomedical|TCBP: Company Long-Term Loans and Borrowings|Company Long-Term Debt Third Harmonic Bio, Inc (THRD)